Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod. Roskell NS, Zimovetz EA, Rycroft CE, Eckert BJ, Tyas DA Curr Med Res Opin. 2012 May; 28(5):767-80. Epub 2012 Apr 24. PMID: 22462530. Abstract CommentRecommendBookmarkWatch